Ozempic and Sex: The Surprising Sexual Side Effects of GLP-1s

You may notice changes to your sexual performance and love life if you take glucagon-like peptide-1 (GLP-1) agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepound, Mounjaro). These medications are prescribed primarily to address blood sugar issues and weight loss, but they can also affect your brain, personality, and self-esteem, potentially leading to changes in the bedroom, for better or worse.
Although some sexual side effects of GLP-1s may be related to the medications themselves, others come from weight loss or changes to body image. Most research into the sexual side effects of GLP-1 medications is still very preliminary, and the reports on these changes are driven by anecdotes and social media as much as they are by clinical trials.
1. Sex Drive
Some researchers have begun to investigate how GLP-1 drugs might affect your libido, or sex drive.
“It’s not surprising [that GLP-1 medications] might also affect other forms of pleasure, including sex,” Szoke says.
Szoke adds that he has had patients who have seen a boost to their sex drive after starting a GLP-1 medication but that it’s hard to tell if that’s related to the drug or the weight loss.
“Their self-esteem and confidence might be up,” he says. “But what if the drug helped them start drinking less or smoking less marijuana? It’s all connected. We can’t pinpoint one cause or effect without more research.”
“It’s very plausible that losing weight with help from a GLP-1 can boost your sex drive, not because of the GLP-1, but simply because of the weight loss, especially the fat around the abdomen,” Szoke says.
2. Inability to Orgasm
3. Increased Fertility
“If a woman is living with obesity, this means there is likely also significant inflammation and potentially abnormal testosterone levels,” says Szoke, adding that obesity can affect ovulation and menstrual cycles, as well.
4. Erectile Dysfunction
Some males have reported having erectile dysfunction while taking GLP-1s, though others have noted an opposite effect.
“If losing a lot of weight improved a person’s blood pressure levels, for example, then they’ll probably see a boost in their ability to get and maintain an erection,” Szoke says. “But some people might be more susceptible to the effects on smooth muscle function.”
Erectile dysfunction could be the sign of other health issues unrelated to GLP-1 medications. Contact your healthcare provider if you are experiencing symptoms.
5. Premature Ejaculation
In addition to erectile dysfunction, some males have reported ejaculating sooner than wanted during sex, known as premature ejaculation, while taking GLP-1 medications.
Premature ejaculation has a variety of potential causes, some physical and some mental.
Diabetes and obesity are considered risk factors, in addition to heart disease, high blood pressure, and other conditions affecting hormone balance, such as hyperthyroidism.
6. Dating Life Changes
A GLP-1 treatment can have a major impact on your love life. Significant weight loss can change your self-esteem, confidence in dating, current relationships, and sexual performance.
Not all users report positive changes. Sixteen percent of respondents said they experienced a decrease in sexual desire, compared with 18 percent who saw an increase. Potentially negative effects of weight loss may include saggy skin throughout many areas of the body, side effects commonly referred to with names like “Ozempic butt” or “Ozempic face,” which can negatively affect appearance and self-confidence.
“Sagging skin is really impossible to avoid when you lose a lot of weight quickly,” Szoke says. “While skin removal surgery isn’t always an option, it’s important to also work with a therapist and focus on your mental health throughout this transition. Your weight is not just physical. It is a big part of your identity.”
7. ‘Ozempic Penis’ and ‘Ozempic Vulva’
Some people who have taken GLP-1 medications have said on social media that they have noticed an increase in penis size, weakness in vaginal muscles, or vaginal looseness. Szoke says that GLP-1 medications will not change the size of your sexual organs, despite rumors saying otherwise. These changes are likely the result of weight loss and sagging skin, which can change the appearance of the genital area.
“No, we have no reason to believe Ozempic can suddenly increase the length of your penis,” Szoke says. “But weight loss can have surprising benefits beyond simply reducing the bulk around that area of your body.”
Weight loss with GLP-1s can lead to various changes in the body, Szoke says. Primarily, it may lead to fat loss in unintended areas, including the breasts, buttocks, and even the labia. Men also store body fat around the base of the penis in the groin.
“When you lose a significant amount of body fat quickly, several areas of your body are inevitably going to have that looser skin,” Szoke says. “This can be really hard to deal with, especially in the stomach and the arms. Body fat definitely accumulates in the vaginal area, too.”
The Takeaway
- Glucagon-like peptide-1 (GLP-1) medications not only help manage weight and diabetes issues but also may have sexual side effects.
- Changes to libido, ability to have an orgasm, and fertility are among reported GLP-1 side effects.
- Research is still needed to determine if many side effects are related to medication or other factors, such as weight loss or blood sugar.
- GLP-1 medications will not change genitalia size, though losing a significant amount of weight could make body parts appear different.
Resources We Trust
- Cleveland Clinic: Ozempic for Weight Loss: Who Should Try It and Will It Work?
- Brown University Health: The Psychological Side of Weight Loss
- Endocrinology: GLP-1 and Its Analogs: Does Sex Matter?
- Harvard Health Publishing: How Does Ozempic Work? Understanding GLP-1s for Diabetes, Weight Loss, and Beyond
- Mayo Clinic: Let’s Talk Low Libido
- Arillotta D et al. Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights From Social Media Using a Mixed-Methods Approach. Brain Sciences. June 20, 2024.
- Mohammed GF et al. Tirzepatide Affect Sexual Function in Women: Case Report. Clinical Medicine Insights: Case Reports. June 6, 2025.
- Conley M. 5 Things to Know About GLP-1s and Addiction. Stanford Medicine. April 1, 2025.
- Brzozowska MM et al. Sex-Differential Testosterone Response to Long-Term Weight Loss. International Journal of Obesity. July 16, 2024.
- Visvabharathy V et al. Anorgasmia Following Initiation of GLP-1 Agonist. Sexual Medicine. June 2025.
- Vasoconstriction. Cleveland Clinic. August 9, 2021.
- ‘Ozempic Babies’: How GLP-1 Agonists Affect Fertility. Cleveland Clinic. March 10, 2025.
- Pavli P et al. Infertility Improvement After Medical Weight Loss in Women and Men. International Journal of Molecular Sciences. February 5, 2024.
- Zhou L et al. Effects of GLP1RAs on Pregnancy Rate and Menstrual Cyclicity in Women With Polycystic Ovary Syndrome: A Meta-Analysis and Systematic Review. BMC Endocrine Disorders. November 8, 2023.
- Liao B et al. Prescribing Ozempic and Wegovy for Weight Loss Is Associated With an Increased Risk of Erectile Dysfunction and Hypogonadism in Non-Diabetic Males. Journal of Sexual Medicine. February 5, 2024.
- An H et al. Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Erectile Dysfunction: A Drug Target Mendelian Randomization Study. Frontiers in Endocrinology. November 13, 2024.
- Langroudi AP et al. GLP-1 Receptor Agonists: From Metabolic Benefits to Sexual Health Concerns — an Analysis of UA Insurance Claims Data. Journal of Urology. May 1, 2025.
- Cadet L. Beyond Weight Loss: 59 percent of GLP-1 Users Say the Prescription Drug Changed Their Dating Lives. DatingAdvice.com. August 25, 2025.

Diala Alatassi, MD, FACP
Medical Reviewer
Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care. By integrating medical expertise with a supportive and motivational approach, Dr. Alatassi fosters a partnership with each patient, guiding them with empathy and respect, to ensure they feel confident and capable of making lasting changes for their overall well-being.
In her free time, she enjoys spending time outdoors with family and friends and traveling.

Ginger Vieira
Author
Ginger Vieira has lived with type 1 diabetes and celiac disease since 1999, and fibromyalgia since 2014. She is the author of Pregnancy with Type 1 Diabetes, Dealing with Diabetes Burnout, Emotional Eating with Diabetes, and Your Diabetes Science Experiment.
Ginger is a freelance writer and editor with a bachelor's degree in professional writing, and a background in cognitive coaching, video blogging, record-setting competitive powerlifting, personal training, Ashtanga yoga, and motivational speaking.
She lives in Vermont with a handsome husband, two daughters, and a loyal dog named Pedro.